Comparative analysis of anthropometric parameters and their association with metabolic health in patients with obesity
DOI:
https://doi.org/10.2478/AMB-2026-0066Keywords:
anthropometrics, obesity, metabolic health, body shape index, body roundness index, conicity index, relative fat mass, weight-adjusted waist indexAbstract
Abstract. Background and aim: Body mass index (BMI) is the cornerstone of obesity classification. As the prevalence of obesity as a chronic disease increases, more precise stratification tools are being explored. The aim of this study is to compare established and alternative anthropometric parameters in terms of their association with metabolic health indices in adults with BMI ≥ 25 kg/m2. Materials and methods: Cross-sectional analysis was performed on first-visit assessment data of 401 individuals from an outpatient endocrinology clinic. Weight, height, and waist circumference values were used to calculate the following anthropometrics: waist-to-height ratio (WHtR), Body Shape Index (ABSI), Body Roundness Index (BRI), Conicity Index (CI), Weight-adjusted Waist Index (WWI), and Relative Fat Mass (RFM). The outcomes of interest were metabolic laboratory indices of glycemia (FPG, HbA1c), lipid metabolism (LDL, TG), and hepatic enzymes (ALT, GGT). After log-transformation, they were standardized and combined into glycemic, lipid, hepatic, and overall metabolic burden composite scores. Hierarchical linear regression models adjusted for age and sex were used to measure the association between each anthropometric index and the composite scores. Incremental explained variance (ΔR2) and regression coefficients were compared. Results: The strongest association with the overall metabolic composite was shown by RFM (β = 0.480, 95% CI = 0.269-0.692; ΔR² = 0.085), followed by WHtR (ΔR² = 0.080), BMI (ΔR² = 0.076), and BRI (ΔR² = 0.076). ABSI, CI, and WWI showed no significant incremental contributions. BMI showed the largest ΔR² for the glycemic composite, whereas RFM ranked highest for lipid and hepatic composites. Conclusion: Waist-based indices – particularly RFM and WHtR – were most consistently associated with composite metabolic laboratory burden in routine outpatient practice.
References
Busetto L, Dicker D, Frühbeck G, et al. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024 July 5;1–5.
Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025 Jan; S2213858724003164.
Yao Z, Dardari ZA, Razavi AC, et al. Prevalence of clinical obesity versus BMI-defined obesity among US adults: a cohort study. Lancet Diabetes Endocrinol. 2025 June; S2213858725001597.
Blundell JE, Dulloo AG, Salvador J, Frühbeck G, on behalf of the EASO SAB Working Group on BMI G. Beyond BMI – Phenotyping the Obesities. Obes Facts. 2014 Oct 23;7(5):322–8.
Romero-Corral A, Somers VK, Sierra-Johnson J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010 Mar;31(6):737–46.
Ahmed KY, Aychiluhm SB, Thapa S, et al. Cardiometabolic Outcomes Among Adults With Abdominal Obesity and Normal Body Mass Index. JAMA Netw Open. 2025 Oct 17;8(10):e2537942.
Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011 Oct 4;183(14):E1059–66.
Dulloo AG, Jacquet J, Solinas G, et al. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes. 2010 Dec;34(S2):S4–17.
Goossens GH. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function. Obes Facts. 2017 July;10(3):207–15.
Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis: Waist-to-height ratio as a screening tool. Obes Rev. 2012 Mar;13(3):275–86.
Zazai R, Wilms B, Ernst B, et al. Waist Circumference and Related Anthropometric Indices Are Associated with Metabolic Traits in Severely Obese Subjects. Obes Surg. 2014 May;24(5):777–82.
Piqueras P, Ballester A, Durá-Gil JV, et al. Anthropometric Indicators as a Tool for Diagnosis of Obesity and Other Health Risk Factors: A Literature Review. Front Psychol [Internet]. 2021 July 9 [cited 2025 Jan 4];12. Available from: https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2021.631179/full
Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep. 2018 Nov 13;8(1):16753.
Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity. 2013;21(11):2264–71.
Woolcott OO, Bergman RN. Relative fat mass (RFM) as a new estimator of whole-body fat percentage ─ A cross-sectional study in American adult individuals. Sci Rep. 2018 July 20;8:10980.
Krakauer NY, Krakauer JC. A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index. Li S, editor. PLoS ONE. 2012 July 18;7(7):e39504.
Valdez R, Seidell JC, Ahn YI, Weiss KM. A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study. Int J Obes Relat Metab Disord. 1993 Feb 1;17(2):77–82.
Wu Q, Qin K, Wang Y, Nie H. Anthropometric indices and their predictive ability on metabolic syndrome in west China. Int J Diabetes Dev Ctries. 2022 Oct 1;42(4):666–82.
Wu L, Zhu W, Qiao Q, et al. Novel and traditional anthropometric indices for identifying metabolic syndrome in non-overweight/obese adults. Nutr Metab. 2021 Jan 6;18:3.
Yin T, Wang J, Lan X, et al. Different obesity indicators and their correlation with hypertension, diabetes, and dyslipidemia in 35–74 years rural residents in Northwest China. Front Endocrinol [Internet]. 2025 June 9 [cited 2025 Nov 21];16. Available from: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1346193/full
Al-Shami I, Al-Dalaeen A, Agraib L, Alkhatib B. Obesity indices may affect and reflect the blood glucose and lipid profile values. Healthc Low-Resour Settings. 2024 Dec 4; DOI:10.4081/hls.2024.12865
Fahami M, Hojati A, Farhangi MA. Body shape index (ABSI), body roundness index (BRI) and risk factors of metabolic syndrome among overweight and obese adults: a cross-sectional study. BMC Endocr Disord. 2024 Oct 28;24(1):230.
Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol. 2008 June 5;7(1):17.
Okosun IS, Boltri JM, Lyn R, Davis-Smith M. Continuous Metabolic Syndrome Risk Score, Body Mass Index Percentile, and Leisure Time Physical Activity in American Children. J Clin Hypertens. 2010;12(8):636–44.
Shafiee G, Kelishadi R, Heshmat R, et al. First report on the validity of a continuous Metabolic Syndrome score as an indicator for Metabolic Syndrome in a national sample of paediatric population – the CASPIAN-III study. Endokrynol Pol. 2013;64(4):278–84.
DeBoer MD, Gurka MJ. Clinical utility of metabolic syndrome severity scores: considerations for practitioners. Diabetes Metab Syndr Obes. 2017 Feb 20;10:65–72.
Murray JS. Multiple Imputation: A Review of Practical and Theoretical Findings. Stat Sci. 2018 May;33(2):142–59.
Zatterale F, Longo M, Naderi J, et al. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol. 2020 Jan 29; 10:1607.
Finer N. Medical consequences of obesity. Medicine (Baltimore). 2015 Feb; 43(2):88–93.
Vekic J, Stefanovic A, Zeljkovic A. Obesity and Dyslipidemia: A Review of Current Evidence. Curr Obes Rep. 2023 Sept 1; 12(3):207–22.
Hosseini SA, Alipour M, Sarvandian S, et al. Assessment of the appropriate cutoff points for anthropometric indices and their relationship with cardio-metabolic indices to predict the risk of metabolic associated fatty liver disease. BMC Endocr Disord. 2024 June 4;24(1):79.
Chaquila JA, Ramirez-Jeri G, Miranda-Torvisco F, et al. Predictive ability of anthropometric indices for risk of developing metabolic syndrome: a cross-sectional study. J Int Med Res. 2024 Nov 1;52(11):03000605241300017.
Mahdavi-Roshan M, Rezazadeh A, Joukar F, et al. Comparison of anthropometric indices as predictors of the risk factors for cardiovascular disease in Iran: The PERSIAN Guilan Cohort Study. Anatol J Cardiol. 2021;25(2):120.
Yang H, Zhang M, Nie J, et al. Associations of obesity-related indices with prediabetes regression to normoglycemia among Chinese middle-aged and older adults: a prospective study. Front Nutr [Internet]. 2023 May 19 [cited 2025 Nov 19];10. Available from: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2023.1075225/full
Lee BJ, Yim MH. Comparison of anthropometric and body composition indices in the identification of metabolic risk factors. Sci Rep. 2021 May 11;11(1):9931.
Gavrailova M, Elenkova A, Robeva R. Differences in Metabolic Parameters in Patients with Different Degrees of Obesity. Acta Medica Bulg. 2026 Jun 16;53(2):22–8. doi:10.2478/amb-2026-0055
Stoynova M, Lilova L, Petrova D, et al. Prevalence of Metabolic Syndrome and its Components in Patients with Controlled Graves’ Disease. Acta Medica Bulg. 2024 Mar 16;51(1):17-24. doi:10.2478/amb-2024-0003
Downloads
Published
Issue
Section
License
Copyright (c) 2026 P. Ivanov, Y. Assyov, R. Tafradjiiska-Hadjiolova, T. Handjieva-Darlenska (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
